1548 — Genscript Biotech Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapSucker Stock

Annual balance sheet for Genscript Biotech, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	R2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	427	771	1,403	1,463	1,928
Net Total Accounts Receivable
Net Total Receivables	96.4	167	167	172	300
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	554	993	1,639	1,765	2,353
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	274	385	505	647	751
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	889	1,447	2,234	2,546	3,387
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	225	328	413	546	495
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	507	546	1,188	1,536	1,996
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	383	902	1,046	1,011	1,391
Total Liabilities & Shareholders' Equity	889	1,447	2,234	2,546	3,387
Total Common Shares Outstanding